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Abstract 
Deoxynivalenol (DON) is a mycotoxin produced by Fusarium spp. Among monogastric farm 
animals, swine are the most susceptible to DON as it markedly reduces feed intake and decreases 
weight gain. DON has also been shown to increase susceptibility to viral infections; therefore the 
objective of this study was to investigate in vitro impact of DON on porcine reproductive and 
respiratory syndrome virus (PRRSV). Permissive cells were infected or not with PRRSV and 
were treated with increasing concentrations of DON. Cell survival and mortality were evaluated 
by determining the number of viable cells with a tetrazolium compound and by measuring lactate 
dehydrogenase (LDH) release, respectively. Virus titration and antiviral cytokines mRNA 
expression were evaluated by quantitative PCR. DON significantly affected the survival of 
noninfected cells in a dose dependent manner. However, DON concentrations between 140 and 
280 significantly increased the survival of cells infected with PRRSV. These concentrations 
significantly decreased PRRSV replication by inducing a pro-inflammatory cytokines 
environment and an early activation of apoptosis, which in turn seem to interrupt viral 
replication. For the first time, this study showed that DON had significant effects on the survival 
of PRRSV infected cells and on virus replication, in a dose dependent manner. 
Key words: Deoxynivalenol, PRRSV, in vitro, virus replication, swine. 
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1- INTRODUCTION  
Deoxynivalenol (DON) is a trichothecene mycotoxin produced by many Fusarium spp mold, 
often found in feed and other organic substrates. DON is a major contaminant of cereal grains 
such as wheat, barley and corn (Binder et al., 2007). Among farm animals, pigs show a great 
sensivity to DON, and because of the high proportion of grains in their diets, pigs are frequently 
exposed to this mycotoxin (D'Mello et al., 1999). DON usually enters the body via oral route and 
subsequently encounters intestinal epithelial cells, which represent the primary target for 
alimentary intoxication. Once absorbed, DON decreases cell protein synthesis and impairs 
immune system cells that appear to be especially sensitive (Pestka, 2008). 
Studies in farm and laboratory animals reveal that DON elicits a complex spectrum of toxic 
effects. Upon acute exposure to high concentrations, animal exhibits a “radiomimetic” shock-like 
response that includes diarrhea, vomiting, leukocytosis and haemorrhage, with extremely high 
concentrations can result in death (Ueno, 1984). Chronic exposure to DON can cause anorexia, 
reduced weight gain, diminished nutritional efficiency, and immune modulation (Rotter et al., 
1996). One study reported that pigs fed diets containing 2 and 4 mg/kg of DON exhibited a dose-
related decrease in weight gain within the first 8 weeks (Bergsjø et al., 1992). In addition, the 
immune system is particularly sensitive to DON and can be either stimulated or suppressed 
depending on doses, exposure frequency, timing and the functional immune assay being 
employed. Leukocytes, most notably mononuclear phagocytes, play a likely central role in the 
acute and chronic toxicity evoked by DON. Low concentrations of DON induce expression of an 
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early proinflammatory response at mRNA and protein levels, while high concentrations promote 
rapid onset of leukocyte apoptosis (Pestka and Amuzie, 2008). 
As classically observed for many trichothecenes, DON inhibits protein synthesis in vivo and in 
vitro. The mechanism for translation inhibition by DON and other trichothecenes involves 
interference with peptidyl transferase function on ribosome with consequent impairment of 
initiation and elongation (Shifrin and Anderson, 1999). Moreover, DON induces the activation of 
mitogen-activated protein kinases (MAPKs) and extracellular signal-regulated kinase (ERK) in 
macrophages and monocytes mediating upregulation of proinflammatory cytokines expression as 
well as apoptosis (Pestka, 2010).  
In cases of mycotoxin-induced immunosuppressive effects on cellular and/or humoral immune 
responses a concomitant decrease in host resistance to infectious diseases has been reported 
(Oswald et al., 2005). In mice, consumption of feed contaminated with T-2 toxin, another 
trichothecene, increased the susceptibility to Herpes simplex virus-1 (HSV-1) infection, by 
allowing virus proliferation, ultimately resulting in the death of mice naturally resistant to HSV-1 
(Friend et al., 1983). Other studies in mice suggests that DON compromised resistance to enteric 
(Li et al., 2005) and respiratory (Li et al., 2007) reovirus infection.  
Porcine reproductive and respiratory syndrome (PRRS) is one of the most economically 
important porcine infectious disease worldwide (Neumann et al., 2005). PRRS is caused by a 
virus (PRRSV) that was first isolated from tissues of piglets and from blood samples of sows 
affected by PRRS in 1991 in the Netherlands using porcine alveolar macrophages (Wensvoort et 
al., 1991) and later in North America (Collins et al., 1992). On the basis of similar morphology, 
genomic organization, replication and transcription strategy, and protein composition, PRRSV is 
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classified in the genus Arterivirus, which belongs to the Arteriviridae family within the order of 
Nidovirales (Cavanagh, 1997). PRRSV is an enveloped virus containing a positive strand RNA 
genome of approximately 15k nucleotides. PRRSV causes severe reproductive impairment in 
breeding animals and respiratory problems in pig of all ages (Music and Gagnon, 2010). The 
virus infects a specific subset of macrophages; alveolar macrophages in pigs (Duan et al., 1997). 
In vitro, primary porcine alveolar macrophages (PAM) and MARC-145 cells are known to be 
susceptible to the virus (Mengeling et al., 1995). Since DON is frequently encountered in pig 
diets, its presence could exacerbate viral infections such as PRRSV. Currently, there is no in 
vitro model that can determine the impact of DON on PRRS infection at the cellular level. 
Therefore, the objective of this study was to evaluate the in vitro effect of DON in PRRSV 
infected cells.  
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2- MATERIAL AND METHODS 
2.1 Cells and Virus 
All cell culture products were purchased from Life technologies (Burlington, ON, Canada) 
unless otherwise specified. MARC-145 cells, known to be permissive to PRRSV (Kim et al., 
1993), were grown in MEM medium supplemented with 5 U/ml penicillin, 5 µg/ml 
streptomycin, 2.5 µg/ml fungizone (Wisent inc. St-Bruno, QC, Canada), 10 mM HEPES and 
10% fetal bovine serum (FBS) (Wisent inc., St-Bruno, QC, Canada). Cell viability was evaluated 
by trypan blue exclusion technique and cells were adjusted to a final concentration of 2.5X105 
viable cells/ml. A volume of 100 µl/well was then plated into 96-well microtiter plates and 
incubated at 37°C for 24 h in a humidified 5% CO2 incubator. 
All experiments involving pigs were conducted in accordance with the guidelines and policies of 
the Canadian Council on Animal Care. PAM cells were obtained from broncho-alveolar lavage 
of 42 to 70 day old PRRSV-negative piglets. Two days prior the lavage, piglets were injected 
with 4 ml/kg of tylosin (Tylan®200, Elanco, Greenfield, IN, USA). Piglets were anesthetised by 
intramuscular injections of 2 mg/kg of azaperon (Stresnil, Janssen pharmaceutica, Beerse, 
Belgium), 2 mg/kg xylazine (Xylamax, Bimeda-MTC animal health, Cambridge, ON, Canada) 
and 20 mg/kg ketamine (Vetalar, Bioniche animal health, Belleville, ON, Canada) and sacrificed 
by intravenous overdose of sodium pentobarbital (Eutanyl Forte 540, Bimeda-MTC animal 
health, Cambridge, ON, Canada). Lungs were then removed and washed with 500 ml of sterile 
phosphate buffer saline solution (PBS) supplemented with 5 U/ml penicillin, 5 µg/ml 
streptomycin and 100 µg/ml gentamicin. Broncho-alveolar lavage fluid was centrifuged at 400 × 
g for 10 min, washed in PBS and cell pellets were resuspended in DMEM with 20% FBS, 2 mM 
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L-glutamine, 10 mM HEPES, 1% essential amino acids, 5 U/ml penicillin, 5 μg/ml streptomysin 
sulfate, 100 μg/ml gentamycin, 2.5 µg/ml fungizone and 10% DMSO. Cell concentration was 
adjusted to 1x107 cells/ml and cells were stored frozen in liquid nitrogen until use. Prior to 
experiment, cells were thawed, washed twice in 20 ml of DMEM and resuspended in DMEM 
supplemented as above except without DMSO. Viable cell count was determined by trypan blue 
exclusion and cells were adjusted to a final concentration of 1x106 viable cells/ml. A volume of 
100 µl/well was then plated into 96-well plates and incubated for 24 h at 37°C in a humidified 
5% CO2.  
Viral stock used for this study was Quebec reference PRRSV strain, IAF-Klop (Mardassi et al., 
1995) and European reference strain LV (Wensvoort et al., 1991). Virus production, titrations 
and titre calculations (TCID50 values) were performed following infection of MARC-145 cells as 
previously described (Gagnon et al., 2008). 
2.2 Viral infection and DON treatment  
After 24 h of cell incubation, the medium was replaced by a medium containing an infectious 
dose of 0.5 MOI and 1 MOI of PRRSV for MARC-145 and PAM cells, respectively. As control, 
medium alone was added for noninfected treatments. After 3 h incubation, the medium was 
removed again and cells were treated with increasing concentrations of DON (Biopure, Tulln, 
Austria); 70, 140, 280, 560 and 1200 ng/ml and were incubated for 72 h. Cell viability and 
mortality were then determined. Medium alone was added as control, since methanol 
concentration used for DON-dilution stock has no effect on different assays (data not shown). 
Each treatment was performed in triplicate.  
2.3 Determination of cell viability 
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Cell viability was measured with CellTiter 96® Aqueous One Solution Cell Proliferation Assay 
(Promega, Madison, WI, USA) at 72 h post-infection (pi). To this aim, 20 µl of the CellTiter 
96® Aqueous substrate were added to the cells and additionally incubated for 1 h at 37°C in a 
humidified 5% CO2. Absorbance was measured at 490 nm with a SynergyTM HT multi-detection 
microplate reader (Biotek, Winooski, VT, USA). 
2.4 Determination of cell mortality 
Based on LDH release, cell mortality was measured using CytoTox 96® Non-Radiactive 
Cytotoxicity Assay (Promega, Madison, WI, USA) at 72 h. A volume of 50 µl of supernatant 
was transferred to a new 96-well plate. Then 50 µl of the reconstituted substrate mix was added 
to each well, plate was covered and incubated at room temperature in the dark for 30 min. 
Finally, 50µl of the stop solution was added to each well and absorbance was taken at 490 nm as 
above. For the estimation of maximal releasable LDH, remaining cells were lysed by adding 100 
μl of distilled water and scrapping using a pipette tip. Maximal releasable LDH was calculated as 
the sum of LDH detected in the cell culture supernatant of non treated cells and LDH released 
after induced lysis of remaining cells. Medium alone was used as control of LDH activity. Data 
were expressed as mortality rate (%), which was calculated as follows; [(treatment measured 
LDH activity - LDH activity of control) / (maximal releasable LDH activity - LDH activity of 
control)]×100.  
2.5. Detection of viral antigen by immunofluorescence 
Presence of PRRSV antigen in infected cells was determined by immunofluorescence assay. 
Briefly, cells infected and treated as in section 2.2 were fixed and permeabilized at 72 h pi with a 
50% methanol / 50% acetone solution. Noninfected cells were included as negative control. 
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After 30 min incubation at room temperature, the methanol/acetone solution was removed and 
cells were washed three times with PBS. Then, α7 rabbit monospecific antisera, a specific anti-N 
PRRSV protein antibody (Gagnon et al., 2003) was diluted 1/200 in PBS and added to the cells 
and incubated at room temperature for 90 min. Cells were then washed and incubated for 60 min 
with 1/75 dilution of anti-rabbit specific antisera FITC conjugated in PBS. Finally, cells were 
visualized using a DMI 4000B reverse fluorescence microscope, images were taken with a DFC 
490 digital camera and analyzed using Leica Application Suite Software, version 3.8.0 (Leica 
Microsystems Inc., Richmond Hill, Canada). 
2.6. Determination of virus titers by quantitative PCR 
To determine virus titer after DON treatment, cells were infected and treated as described in 
section 2.2. After 72 h pi, viral RNA was extracted as previously described (Gagnon et al., 
2008). Virus detection was performed using a commercial PRRSV real-time PCR diagnostic kit 
(Tetracore, Rockville MD, USA). Quantification of PRRSV was determined by comparing 
sample results to a standard curve based on the amount of serially diluted IAF-Klop PRRSV 
reference strain (Gagnon et al., 2003) titrate after infection of MARC-145 cells and expressed as 
TCID50/ml. 
2.7. Cytokine mRNA expression 
Cytokine mRNA expression was determined in PAM cells. The cells were prepared in 6-well 
plates to a final concentration of 1x106 viable cells/ml in 1.5 ml of medium; then the plates were 
incubated in a humidified incubator 5% CO2 for 24 h. The medium was removed and fresh 
medium was added containing 1 MOI of IAF-Klop virus strain. As negative control, medium 
alone was added for noninfected cells. Infected and noninfected cells were incubated for 3 h, 
  
 11
then medium was removed and cells were treated with media containing 0, 280, or 1200 ng/ml of 
DON for 3 h. Total RNA from samples was isolated using Quiagen RNeasy Mini Kit (Quiagen, 
Toronto, ON, Canada) according to manufacturer’s instructions. Extracted RNA was 
resuspended in 30 µl of Rnase free water. Total RNA from samples was stored at -80° until RT 
transcription. Quantification of RNA was performed with a Nanodrop (NanoDrop Technologies, 
Inc., Wilmington, Delaware, USA). One μg of total RNA was reverse-transcribed using the 
QuantiTect reverse transcription kit (Qiagen, Mississauga, ON, Canada) according to 
manufacturer’s instructions. The cDNA was amplified using the SsoFast™ EvaGreen® 
Supermix kit (Bio-rad, Hercules, CA, USA). The PCR amplification program for all cDNA 
consisted of enzyme activation step of 3 min at 98°C, followed by 40 cycles of denaturing step 
for 2 sec at 98°C and annealing/extension step for 5 sec at 58°C. The primers used for 
amplification of different cDNA target are presented in Table 1. All primers were tested to 
achieve amplification efficiency between 90% and 110% (data not shown). The primer 
sequences were all designed from the NCBI GenBank mRNA sequences using web-based 
software primerquest from Integrated DNA technologies. Bio-Rad CFX-96 sequence detector 
apparatus was used for the cDNA amplification. Quantification of differences between groups 
was calculated using the 2-ΔΔCt method. β2-microglobulin was used as normalizing gene to 
compensate for potential differences in cDNA amounts. Noninfected PAM cells were used as a 
calibrator reference in the analysis. 
2.8. Caspase-3 activation 
Apoptosis was also assessed by detecting procaspase 3 activation. PAM cells were prepared in 6-
well plates as described above. As positive control, cells were treated with a cocktail of known 
apoptosis inductor containing 20 μg/ml of cycloheximide, 0.5 μg/ml actinomycin D and 2 μg/ml 
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vinblastin sulfate (all from Biomol International, LP, Plymouth meeting PA, USA). At 3 and 6 h 
post-treatment, cells were disrupted in a cell lysis solution (50 mM HEPES, 100 mM NaCl, 0.1% 
CHAPS 1 mM DTT 100 μM EDTA, pH 7.4). Before the assay, protein concentration of lysate 
was determined by Bradford assay (Bio-rad, Mississauga, On, Canada) according to 
manufacturer’s instructions. For the assay, 50 μg of cell lysates total protein were diluted in 
assay buffer (50 mM HEPES, pH 7.4, 100 mM NaCl, 10% glycerol, 0.1% CHAPS, 100 μM 
EDTA and 10 mM DTT) to adjusted volume to 90 μl. Then, 10 μM of specific substrate for 
caspase 3, Ac-DEVD-AFC fluorogenic substrate (Enzo, life sciences, Farmingdale, NY, U.S.A.), 
was added and the rate of fluorescence released was monitored with a 96-well plate fluorescence 
reader (Biotek, Winooski, VT, USA). Results were expressed as relative fluorescence released 
(relative fluorescence units or RFU) per second per μg of cell lysates. 
2.9. Statistical analysis 
All statistical analyses were performed using GraphPad Prism software (version 4.03, GraphPad 
Prism software Inc., San Diego, CA). Data were analysed statistically by application of a one-
way ANOVA with tukey multiple comparison test. For viability and mortality measurement, 
means of noninfected versus infected cells were compared by applying Student′s unpaired ′t′ test, 
for each DON concentration. P < 0.05 was considered reflecting statistically significant 
differences. Data labeled with superscripts of different letters indicate significant difference 
between data sets. 
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3- RESULTS 
3.1- Effects of DON on cell viability 
Effect of DON was evaluated on PRRSV permissive cells (MARC-145 and PAM) using 
increasing concentrations of DON 70, 140, 280, 560, 1200 ng/ml. Cells were treated for 72 h and 
their viability was evaluated. Results showed that DON concentrations of 560 ng/ml or higher 
were significantly detrimental to the survival of MARC-145 and PAM cells at 72 h (Fig. 1A,B). 
For MARC-145 cells (Fig. 1A), a decrease of absorbance in non-treated cells was observed 
compared to DON-treated cells, even though cell morphology appeared to be normal under light 
microscopy (Sup. 1A) suggesting a nonlinearity of the assay. This could be explained by the fact 
that different cell types have different levels of metabolic activity. Many factors may affect the 
metabolic activity of cells that consequently affect the relationship between cell number and 
absorbance. For example, anchorage-dependent cells such as MARC-145 that undergo contact 
inhibition may show a change in metabolic activity per cell at high densities, resulting in a 
nonlinear relationship between cell number and absorbance (Cory et al., 1991).  
Viability of cells infected with PRRSV has also been evaluated with aforementioned conditions. 
The viability of noninfected (Fig. 1A, 0 ng/ml DON) and infected MARC-145 cells, not treated 
with DON were similar, even if cytopathic effect was observed under light microscopy (Sup 1B). 
However, a significant (P <0.001) reduction of viable cells was found in PRRSV infected PAM 
cells (Fig. 1B, 0 ng/ml DON) without DON due to the virus cytopathic effect compared to 
noninfected cells. In contrast, there was a significant increase of viable cells at DON 
concentrations within 140 to 280 ng/ml and 70 to 280 ng/ml ranges for MARC-145 (Fig. 1A) 
and PAM (Fig. 1B) cells, respectively. These results indicate that DON concentrations between 
  
 14
140 and 280 ng/ml could significantly reduce the cytopathic effect caused by PRRSV. As for 
noninfected cells, DON concentrations at 560 ng/ml and higher decreased the number of viable 
cells.  
3.2- Effects of DON on cell mortality 
In order to solve the nonlinearity of viability assay for MARC-145 cells and to confirm the 
results of cell viability, cell mortality was evaluated using LDH release as indicator of cell 
membrane integrity, 72 h following the same DON treatment. As for the viability assay, only 
high concentrations of DON increased mortality of MARC-145 cells (Fig. 2A). PAM cells 
appeared to be more sensitive to DON than MARC-145 cells, as concentrations of 280 ng/ml and 
higher of the toxin were sufficient to significantly increase LDH release by these cells (Fig. 2B). 
As expected, PRRSV infected MARC-145 and PAM cells without DON (Fig. 2A, 2B, 0 ng/ml 
DON) had higher (P < 0.001) mortality rate than their noninfected counterparts, because PRRSV 
is a cytopathic virus. Exposure to low concentration of DON progressively decreased mortality 
of infected MARC-145 cells (Fig. 2A) starting at 70 ng/ml and reaching basal level at 140 ng/ml 
or higher. DON concentration required to decrease mortality of infected PAM cells was slightly 
higher than for MARC-145 cells, at 140 ng/ml and 280 ng/ml (Fig. 2B). Since PAM cells 
appeared to be more sensitive to DON toxicity than MARC-145 cells, the mortality rate 
increased again with concentrations over 280 ng/ml. These results confirm those obtained with 
cell viability, that DON concentrations between 140 and 280 ng/ml could significantly reduce 
PRRSV cytopathic effect. These results do not seem related to viral genotype, since similar 
results were obtained with reference European strain LV (Sup. 2).  
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3.3- Effects of DON on PRRSV viral replication 
To test DON effect on PRRSV replication, immunofluorescence experiment was performed to 
detect PRRSV N antigen in MARC-145 infected cells treated with DON. Results showed that the 
staining of PRRSV gradually decreased starting at 140 ng/ml of DON until complete 
disappearance of labeling at 560 ng/ml or higher (Fig. 3A). In order to confirm this result, the 
experiment was performed in PAM cells, the natural target cell of the virus. Cell pellet and 
supernatant were subjected to a quantitative PCR assay to determine virus titer. Results 
demonstrated that PRRSV titer gradually decreased starting at 140 ng/ml of DON until reaching 
basal level at 280 ng/ml or higher (Fig. 3B). Taken all together, these results suggest that DON 
could inhibit PRRSV replication in a dose dependent manner, which may explain the decrease in 
cell mortality caused by DON in infected cells, since the replication of virus was affected. 
3.4 Effect of DON on antiviral and pro-inflammatory cytokines expression 
Relative mRNA expression of some antiviral (IFN-α and IFN-β) and pro-inflammatory (IL-6 and 
TNF-α) genes were measured in PAM cells following exposure to increasing doses of DON (0, 
280 and 1200 ng/ml). Relative mRNA expression of the same genes were also measured on 
PRRSV infected PAM cells exposed to same concentrations of DON (Fig. 4). Results 
demonstrated that the relative expression of all tested cytokines mRNA were upregulated only 
with the highest DON dose, 3 h following exposition to DON alone. However, the increased 
expression of antiviral cytokines mRNAs (Fig. 4A,B) was significantly offset by PRRSV 
infection, which is not the case for pro-inflammatory mRNA such as IL-6 and TNF-α (Fig. 
4C,D).  
3.5 Effect of DON on caspase-3 activation 
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Exposure to DON is also known to induce apoptosis, which could also contribute to the 
inhibitory effect of DON on PRRSV. Apoptosis is characterized by morphological and 
biochemical changes, including caspases activation. In order to evaluate apoptosis triggering, 
caspase-3 like activity was measured. Results showed that caspase-3 activation was increased in 
a dose dependent manner, 3 h and 6 h after DON exposition (Fig. 5A and B). Only 1200 ng/ml of 
DON has increased significantly caspase-3 activity however at 6 h pi, this activity has 
significantly increased also for 280 ng/ml of DON in PRRSV infected cells (Fig. 5B). As for pro-
inflammatory genes, the increase of caspase-3 activation was not significantly changed by 
PRRSV infection. 
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4- DISCUSSION 
Contamination of cereal intended for pigs feeding by toxins produced by various molds and 
fungi is a major problem for livestock production. Among these toxins, DON has drawn more 
attention because of it high occurrence frequency at high concentrations (Glenn, 2007). Pigs 
exposed to feed contaminated with 20 ppm of DON have usually acute toxic effect such as 
vomiting (Young et al., 1983). On the other hand, low concentration of DON such as 1 ppm can 
lead to reduced feed intake and weight gain (Rotter et al., 1994). In addition, DON is also known 
to possess immunomodulatory properties, since high concentrations may result in 
immunosuppression, characterized by a decrease in circulating lymphocytes while low 
concentrations can induce stimulation of cytokine and inflammation associated genes (Pestka 
and Smolinski, 2005). As a consequence, DON and other fusarium toxins have been shown to 
increase susceptibility to viral infections in various animal models (Danicke et al., 2011; Friend 
et al., 1983; Li et al., 2007; Li et al., 2005). 
At cellular level, toxic effect of DON is mainly due to inhibition of protein synthesis (Ueno et 
al., 1973). At molecular level, mechanism of action of DON includes activation of MAPKs and 
ERK, known to be critical for signal transduction in the immune response (Islam et al., 2006; 
Zhou et al., 2003). In turn, these MAPKs mediate upregulation of proinflammatory cytokine and 
chemokine expression as well as apoptosis (Chung et al., 2003; Moon and Pestka, 2002). The 
analysis of cell viability and mortality presented in this study showed that DON concentrations 
of 560 ng/ml and higher were significantly detrimental to the survival of MARC-145 and PAM 
cells. These toxic concentrations were similar to those previously observed for primary porcine 
cells (Doll et al., 2009; Goyarts et al., 2006) where IC50 values were estimated at 503 and 309 
ng/ml for primary macrophages and peripheral blood lymphocytes respectively. Several recent 
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reports indicate that DON induces programmed cell death via extrinsic and intrinsic apoptotic 
pathways (Bensassi et al., 2012; He et al., 2012; Ma et al., 2012). As expected, caspase-3 
activation observed in our experiments strongly suggests that cells exposed to DON probably die 
by apoptosis. 
PRRSV is considered as one of the most important swine pathogens. In vivo, the virus is known 
to infect subsets of pig macrophages that are mainly present in lungs and lymphoid organs (Duan 
et al., 1997). In vitro, PRRSV infects primary cell cultures of PAM (Wensvoort et al., 1991) and 
monkey cell lines such as MARC-145 (Kim et al., 1993), the two models selected for this study. 
In both, PAM and MARC-145 cell models, PRRSV causes observable cytopathic effects 
between 48 h to 72 h pi. Cell viability and mortality showed a rapid cell death caused by PRRSV 
strains used in this study. Interestingly, exposure to sub-toxic DON reduced significantly cell 
mortality triggered by PRRSV, in a dose dependent manner. Our data also showed that specific 
PRRSV antigen content of infected cells was reduced as seen in the immunofluorescence 
experiment. This result was confirmed by qPCR indicating a lower amount of PRRSV genes 
after DON exposure. These results suggest that DON doses between 140 and 280 ng/ml could 
inhibit PRRSV replication which may explain decreased cell mortality caused by DON in 
infected cells. To our knowledge, this study is the first to report an inhibitory effect of DON on 
viral replication at cellular level. Conversely previous report by Li and coauthors (2007) 
demonstrated an in vivo exacerbation of reovirus infection following exposure of DON. 
As previously mentioned, DON is known to mediate upregulation of proinflammatory cytokine 
expression as well as apoptosis (Pestka, 2010). Previous study with PAM cells, showed that 
mRNA expression of inflammatory cytokines peaked quickly, 3 h post-exposure, and declined 
progressively to baseline at 12 h post-exposure (Doll et al., 2009). The analysis of gene 
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expression showed an increase in the expression of type I IFN (-α, -β), IL-6, and TNF-α at 3 h in 
noninfected cells. Data also demonstrated that PRRSV could offset the increase of relative 
expression of type I IFN. Secretion of type I IFNs is a key step in innate immune response to 
viral infection (Kawai and Akira, 2006). Previous studies have demonstrated that PRRSV 
infection results in low type I IFN levels suggesting that PRRSV evolves a strategy to interfere 
with type I IFN signaling pathways, and subsequently to evade innate immune response (Albina 
et al., 1998). A recent review described multiple strategies used by PRRSV for manipulating IFN 
type I response (Sun et al., 2012). Apoptosis is also considered to be an important host defense 
mechanism that interrupts viral replication and eliminates virus-infected cells (Thomson, 2001). 
Other study has shown that PRRSV stimulates anti-apoptotic pathways in macrophages early in 
the infection and that PRRSV-infected macrophages die by apoptosis later. PRRSV confers 
protection to infected macrophages against staurosporine-induced apoptosis (Costers et al., 
2008), but it does not seems to be the case for DON-induced apoptosis. In the light of our results, 
the early activation of pro-inflammatory genes and apoptosis following DON exposure appears 
to be detrimental to PRRSV survival in MARC-145 and PAM cells.  
Whereas mycotoxin concentration in feed is easily measured, exposure of various organs, such 
as lung, to mycotoxins is more difficult to predict. DON was shown to be rapidly and nearly 
completely absorbed, highly distributed, but poorly metabolized in pigs (Goyarts and Danicke, 
2006; Prelusky et al., 1988), resulting in high systemic availability. However, DON is rapidly 
excreted in urine which has been shown to be the main excretory route of this toxin (Goyarts and 
Danicke, 2006). Studies over a wide range of DON concentrations in feed demonstrated a linear 
dose relationship to serum concentration; with a very high inter-individual variation (Danicke et 
al., 2008). Concentration of DON decreased from bile > kidney> serum > liver = muscle. Plasma 
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median of DON concentration in pigs expose to 2 ppm of DON in feed was reported between 10 
to 15 ng/ml (Danicke et al., 2010). Yet, no study has linked in vitro effect of DON to 
concentrations that can predispose pigs to viral infections. It is difficult though to predict the 
degree of exposure necessary for DON to exert its inhibitory effect on PRRSV replication. 
Experiments will be needed to confirm the impact of DON naturally contaminated feed on 
PRRSV infected animals. 
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Figure captions  
Figure1. Effect of DON on cell viability following PRRSV infection. 
Noninfected or PRRSV (IAF-Klop) infected MARC-145 (A) or PAM (B) cells were simulteanously treated 
with increasing concentrations of DON (0, 70, 140, 280, 560 or 1200 ng/ml). Cell viability was measured 
with CellTiter 96® AQueous One Solution Cell Proliferation Assay (Promega) 72 h following DON 
treatment. Data labeled with superscripts of different letters indicate significant difference between 
data sets (P < 0.05). * (P < 0.05), ** (P < 0.01), *** (P < 0.001), compare noninfected with infected cells at 
respective DON concentration. Results are representative of three independent experiments for each 
cell types. 
Figure 2. Effect of DON on cell mortality following PRRSV infection. 
Noninfected  or PRRSV (IAF-Klop) infected MARC-145 (A) or PAM (B) cells were treated simulteanously 
with increasing concentrations of DON (0, 70, 140, 280, 560 or 1200 ng/ml). Cell mortality was evaluated 
by LDH release, with CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega) 72 h following DON 
treatment. Data labeled with superscripts of different letters indicate significant difference between 
data sets (P < 0.05). *** (P < 0.001), compare noninfected with infected cells at respective DON 
concentration. Results are representative of three independent experiments for each cell types.  
Figure 3. Effect of DON on PRRSV replication. 
PRRSV (IAF-KLOP) infected MARC-145 cells were simulteanously treated with increasing concentrations 
of DON (0, 70, 140, 280, 560 or 1200 ng/ml) for 72 h. A) PRRSV viral titers were measured by 
immunofluorescence with a PRRSV N-specific antibody. B) PRRSV infected PAM cells were 
simulteanously treated with the same concentrations of DON for 72 h. PRRSV viral titers were 
measured, in triplicatas, by qPCR. Data labeled with superscripts of different letters indicate significant 
difference between data sets (P < 0.05). 
Figure 4. Cytokine mRNA expression by qPCR. 
Noninfected or PRRSV (IAF-KLOP) infected PAM cells from 3 different pigs were treated with increasing 
concentrations of DON mycotoxin (0, 280, or 1200 ng/ml) for 3 h. The relative mRNA expression of some 
antiviral IFN-α (A) and IFN-β (B) and pro-inflammatory genes IL-6 (C) and TNF-α (D) genes were 
measured by quantitative PCR. The data is expressed in ΔΔCt using the β2-microglobulin gene as the 
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normalizing gene and the noninfected cells as the calibrator reference. Data labeled with superscripts of 
different letters indicate significant difference between data sets (P < 0.05). 
Figure 5. Caspase 3 activation. 
Noninfected or PRRSV (IAF-KLOP) infected PAM cells, from 3 different pigs, were treated with increasing 
concentrations of DON mycotoxin (0, 280, or 1200 ng/ml) for 3 h (A) or 6 h (B). As positive control, cells 
were treated with a cocktail of known apoptosis inductor containing 20 μg/ml of cycloheximide, 0.5 μg/ml 
actinomycin D and 2 μg/ml vinblastin sulfate. The results are expressed as relative fluorescence released 
(relative fluorescence units or RFU) per second per μg of cell lysates. Data labeled with superscripts of 
different letters indicate significant difference between data sets (P < 0.05). 
Supplementary data 1. Morphology of noninfected and PRRSV infected MARC-145 cells under light 
microscopy. 
Noninfected (A) or PRRSV (IAF-KLOP) infected (B) MARC-145 cells, not treated with DON, were visualized 
under light microscope. 
Supplementary data 2: Effect of DON on cell mortality following PRRSV infection: Effect of genotype. 
Noninfected or PRRSV (LV) infected MARC-145 cells were simulteanously treated with increasing 
concentrations of DON mycotoxin (0, 70, 140, 280, 560 or 1200 ng/ml). Cells mortality was evaluated by 
LDH release, with CytoTox 96® Non-Radioactive Cytotoxicity Assay (Promega), 72h following DON 
treatment. Data labeled with superscripts of different letters indicate significant difference between 
data sets (P < 0.05). ** (P < 0.01), *** (P < 0.001), compare noninfected and infected cells at respective 
DON concentration. 
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Figure 4: 
 
0
20
40
60
80
100
a
b
a a a a
A)
PRRSV - - - + + +
DON (ng/ml) 0     280    1200  0     280     1200
IF
N
-
α
 
m
R
N
A
re
la
ti
v
e 
ex
pr
es
si
o
n
( Δ
ΔC
T)
0
10
20
30
40
a
c
b
a a a
B)
PRRSV - - - + + +
DON (ng/ml) 0     280    1200  0     280     1200
IF
N
-
β m
R
N
A
re
la
ti
v
e 
ex
pr
es
si
o
n
( Δ
ΔC
T)
0
2
4
6
8 b
a a
ab
ab
ab
PRRSV - - - + + +
DON (ng/ml) 0     280    1200  0     280     1200
C)
IL
-
6 
m
R
N
A
r
el
at
iv
e 
ex
pr
es
si
o
n
( Δ
ΔC
T)
0
20
40
60
80
a
ab
b
a
ab
b
D)
PRRSV - - - + + +
DON (ng/ml) 0     280    1200  0     280     1200
TN
F-
α
 
m
R
N
A
re
la
ti
v
e 
ex
pr
es
si
o
n
( Δ
ΔC
T)
 
  
 33
Figure 5: 
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Supplmentary data 1: 
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Supplementary data 2 : 
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Table 1 : Primers used for the evaluation of cytokine mRNA expressions. 
Cytokine Primers set 
IL-6 F: 5’-ACTCCCTCTCCACAAGCGCCTT-3’ 
R: 5’-TGGCATCTTCTTCCAGGCGTCCC-3’ 
IFN-α F: 5’-CTGCAATGCCATCTACTCTC-3’ 
R: 5’-GGAATCCAAAGTCCCTTCTG-3’ 
IFN-β F: 5’-CTCTCCTGATGTGTTTCTCC-3’ 
R: 5’-GTTCATCCTATCTTCGAGGC-3’ 
TNF-α F: 5’-GCCCACGTTGTAGCCAATGTCAAA-3’ 
R: 5’-GTTGTCTTTCAGCTTCACGCCGTT-3’ 
B2M F: 5’-CGTGGCCTTGGTCCTGCTCG-3’ 
R: 5’-TCCGTTTTCCGCTGGGTGGC-3’ 
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Highlights 
 
• DON concentrations of 560 ng/ml and higher were detrimental to the survival of PRRSV 
permissive cells such as MARC-145 and PAM 
• DON concentrations between 140 and 280 ng/ml reduced the cytopathic effect caused by PRRSV 
in permissive cells 
• Early activation of pro-inflammatory genes and apoptosis may be detrimental to PRRSV survival 
in DON-exposed permissive cells 
 
